Qiagen
QGEN
#2255
Rank
NZ$15.07 B
Marketcap
NZ$73.00
Share price
-0.66%
Change (1 day)
-12.43%
Change (1 year)

P/E ratio for Qiagen (QGEN)

P/E ratio as of August 2026 (TTM): 22.3

According to Qiagen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.2588. At the end of 2025 the company had a P/E ratio of 22.1.

P/E ratio history for Qiagen from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202522.1-80.14%
2024111321.69%
202326.410.03%
202224.08.63%
202122.0-26.91%
202030.2-118.28%
2019-165-551.21%
201836.6-77.16%
2017160123.3%
201671.765.77%
201543.37.74%
201440.1-41.6%
201368.7140.06%
201228.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Thermo Fisher Scientific
TMO
34.8 56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
57.6 158.95%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
41.4 86.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
31.3 40.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
102 357.99%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.